CaptureSelect™ Biotin Anti-FVIII Conjugate consists of a 13 kDa camelid antibody fragment (affinity ligand) with high affinity and selectivity for both recombinant (full length and B-domain deleted) and plasma derived human Factor VIII (FVIII), through recognition of the human FVIII light chain. The affinity ligand is chemically conjugated to biotin via an appropriate spacer that retains the binding reactivity of the ligand when used in combination with streptavidin-based conjugates or streptavidin pre-coated surfaces.
The CaptureSelect™ Biotin Anti-FVIII Conjugate allows you to:
• Detect, quantitate, and characterize recombinant and plasma derived human FVIII
Applications for CaptureSelect™ Biotin Anti-FVIII Conjugate include ELISA, Western blot, Gyrolab™-based immunoassays, and label-free detection platforms such as those based on surface plasmon resonance (Biacore™ and IBIS-MX96 systems) and bio-layer interferometry (ForteBio™ Octet™ systems).
For Research Use Only. Not for use in diagnostic procedures.